HCPCS Code J7677

Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram
Code effective Jul 01, 2019

HCPCS Section
Drugs administered other than oral method, chemotherapy drugs

J7677 is a valid 2026 HCPCS code meaning Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram or (Revefenacin inh non-com 1mcg) for short. HCPCS J7677 has been effective since 07/01/2019 and applies to Medical care.

HCPCS Code Details - J7677

HCPCS Level II Code
Section J - Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J7677
Description

Long description:
Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram

Short description:
Revefenacin inh non-com 1mcg

HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code D1G - Drugs Administered through DME
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jul 01, 2019
Date added Added Jul 01, 2019

See also

  • HCPCS J7676 · Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg

  • HCPCS J7680 · Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 7/13/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.